
ExpressionMed
Designed medical adhesives for securing wearable diabetic devices.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
* | N/A | - | |
Total Funding | 000k |
ExpressionMed, founded by Meghan Sharkus in 2016, manufactures and sells medical-grade adhesive tapes designed to secure wearable devices for people with diabetes. Sharkus was inspired to start the company as a teenager to help a friend with type 1 diabetes personalize her insulin pump. This led to the creation of a company that now serves a global customer base with what has grown into a multi-million-dollar business.
The company's primary business is direct-to-consumer e-commerce, selling its products through its website. Customers can use HSA/FSA cards for payment. ExpressionMed's products are waterproof, hypoallergenic, and designed not to fray, with customer surveys indicating they can last for over ten days. The product line includes a wide variety of designs and shapes for continuous glucose monitors (CGMs) and insulin pumps, including those from major brands like Dexcom, Freestyle Libre, Medtronic, and Omnipod. The company also offers underpatches to protect skin from device adhesives and other accessories.
Headquartered in Minneapolis, MN, ExpressionMed started after two years of research into finding a comfortable and long-lasting adhesive material. Initial sales began in November 2016 with patches for insulin pumps, followed shortly by tapes for Dexcom devices. The company has received backing from accelerator programs like gBETA and Beta.MN and secured $20.2K in a product crowdfunding campaign in April 2017.
Keywords: medical adhesives, CGM patches, insulin pump tapes, diabetic device accessories, wearable device security, Dexcom adhesives, Libre tapes, Medtronic CGM patches, Omnipod adhesives, waterproof medical tape, hypoallergenic tape, e-commerce, healthcare products, diabetes care, medical supplies, Meghan Sharkus, therapeutic devices, skin-friendly adhesives, infusion set tapes, pediatric diabetes